• HOME
  • About
    • Leadership
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
  • Contact
    Careers News

We are now part of invoX Pharma

    Careers News
  • About
    • Leadership
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
  • Contact

Press Releases

Nov 10, 2021

F-star Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update »

Nov 1, 2021

F-star Therapeutics to Announce Third Quarter Results and Host Conference Call on November 10, 2021 »

Oct 20, 2021

F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics »

Sep 16, 2021

F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021 »

Sep 9, 2021

F-star Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference »

Aug 12, 2021

F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update »

Aug 10, 2021

F-star Therapeutics is Granted Composition of Matter Patent for its Novel Second Generation STING Agonist, SB 11285 »

Aug 4, 2021

F-star Therapeutics Announces Collaboration with MSD to Evaluate FS120 in Combination with KEYTRUDA »

Aug 2, 2021

F-star Therapeutics to Announce Second Quarter Results and Host Conference Call on August 12, 2021 »

Jul 26, 2021

F-star Therapeutics Provides Interim Update on SB 11285 First-In-Human Dose-Escalation Study in Patients with Advanced Solid Tumors »

Jul 9, 2021

F-star Therapeutics to Present at Upcoming Investor Conferences »

Jul 8, 2021

F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors »

May 17, 2021

F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update »

May 10, 2021

F-star Therapeutics to Announce First Quarter Results and Corporate Update Call on May 17, 2021 »

May 7, 2021

F-star Therapeutics, Inc. Announces Pricing of $65 Million Public Offering of Common Stock »

May 6, 2021

F-star Therapeutics, Inc. Announces Proposed Public Offering of Common Stock »

Apr 29, 2021

Cancer Trial Highlights Potential for Checkpoint Inhibitors »

Apr 19, 2021

Study Published in Nature Shows F-Star’s STING Agonist SB 11285 Enhances Preclinical Efficacy of Radiation Therapy »

Apr 10, 2021

F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster »

Apr 1, 2021

F-star Therapeutics Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Oncology Collaboration »

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
Year

About 

Overview Leadership Board of Directors Pharmaceutical Partnerships

Technology 

Overview Our Platform Publications Intellectual Property

Pipeline 

Program Overview FS118 FS120 FS222 SB 11285

 

Investors Careers News Contact Us

Eddeva B920
Babraham Research Campus
Cambridge, CB22 3AT, UK

245 First Street
Riverview II, Floor 18
Cambridge, MA 02142, USA

Disclaimer Privacy Policy Cookie Policy Careers Sitemap

© 2023 F-Star Therapeutics Inc.

We use cookies to give you the best online experience. Please see our cookie policy here. Please let us know if you agree to all of these cookies.
Accept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT